Lipid metabolism dysregulation in late-life depression: peripheral metabolic disturbance, central lipid alterations, and dietary modulation
Abstract
Late-life depression involves neurodegeneration, inflammation, metabolic disruption, and psychosocial stress. Lipid metabolism has drawn increasing attention in this field. This review examines three interconnected aspects: peripheral metabolic disturbance, potential central lipid alterations, and dietary lipid regulation. Peripherally, adverse lipid profiles and lipidomic shifts correlate with depressive symptoms, cognitive decline, and cardiometabolic load. Mechanisms include inflammation, membrane remodeling, mitochondrial dysfunction, and oxidative stress. Centrally, the disorder may involve aberrant membrane phospholipid metabolism, brain region-specific lipid alterations, and apolipoprotein E-mediated transport disruption, affecting myelin integrity, synaptic plasticity, neuroinflammation, and cerebrovascular function. Evidence regarding dietary lipids remains mixed: omega-3 supplementation has not shown a consistent preventive benefit, whereas high-fat, fried, and Western dietary patterns have been associated with depressive outcomes in observational studies. However, much of the current evidence is extrapolated from MDD or general populations, limiting its direct applicability to late-life depression. Future work should combine longitudinal designs, multi-omics, neuroimaging, and intervention studies to establish causality and identify biomarkers and tailored strategies.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.